Table of Contents Table of Contents
Previous Page  261 / 366 Next Page
Information
Show Menu
Previous Page 261 / 366 Next Page
Page Background

PS-21-001

Patella- unusual localisation of bone tumours

J. Jevtic

*

, R. Kovacevic, Z. Vucinic, G. Djuricic, D. Ristic, J. Sopta

*

Institute of Pathology, Belgrade, Serbia

Objective:

Tumours of the patella are very rare. Primary tumours are

much more common than metastases. According to literature, the most

frequent primary patellar neoplasms are chondroblastoma and giant cell

tumour.

Method:

A total of 25094 medical records from Register of bone

and soft tissue lesions biopsies were included in the study.

Results:

Only nine (0.04 %) patients had patellar tumours. Six of these

were benign, one was a pseudotumoural lesion and two was reported as

malignant. Benign primary bone tumours diagnosed in patella were: two

osteochondromas, chondroblastoma, enchondroma, osteoblastoma, cav-

ernous hemangioma. Malignant tumour were: metastasis of urothelial

carcinoma and multiple myeloma. Brown tumour in hyperparathy-

roidism was diagnosed in one case. Eight patients were male, and

just patient with hyperparathyroidism was female. The youngest

patient was a 9 years old boy with osteochondroma and the oldest

was 68 years old male with plasmacytoma. Clinical presentation

was unspecific pain and swelling. A patient with solitary metasta-

tic urothelial carcinoma was presented with pathological fracture.

P a t i e n t s we r e t r e a t e d s u r g i c a l l y, a n d i n t wo c a s e s

(chondroblastoma and metastatic urothelial carcinoma) total

patellectomy was performed.

Conclusion:

Although very rare, patellar neoplasms should be consid-

ered whenever patients complain about symptoms related to knee area.

Early diagnosis and adequate treatment insure excellent prognosis.

PS-21-002

Aquaporin 1 and Fibulin-3 as potential biomarkers of malignant

mesothelioma in workers occupationally exposed to Fluoro-edenite

fibres: A preliminary report

G. Angelico

*

, A. Ieni, R. Caltabiano, C. Loreto, C. Ledda, V. Rapisarda,

G. Tuccari

*

AOU Policlinico G. Martino, Dept. of Human Pathology, Messina, Italy

Objective:

Aquaporin 1 (AQP1) and Fibulin-3 (Fb-3) have been pro-

posed as biomarkers for the diagnosis and prognosis of malignant pleural

mesothelioma (MPM). An increased standardised incidence and mortal-

ity rate due to MPM in Biancavilla, a little town of eastern Sicily (Italy)

was observed in general population exposed to a natural fiber Fluoro-

edenite (FE). The aim of the present study was to investigate the immu-

nohistochemical expression of AQP1 and Fb-3 in a cohort of patients

affected by MPM related to FE exposure.

Method:

Pathological reports, clinical and follow-up data from eight

patients who underwent surgery for MPM, all resident in the town of

Biancavilla and exposed to FE. AQP1 and Fb-3 were processed by

DAKO Autostainer. AQP1 overexpression was defined when

50 % of

tumour membranous cell staining; Fb-3 immunoexpression was achieved

by densitometric and morphometric analyses.

Results:

Immunohistochemical overexpression of AQP1 was document-

ed in 5 cases, which showed a significantly higher disease free survival

(29.1 months) in comparison to that observed in patients with no

AQP1overexpression (7.5 months). In six cases, nuclear and cytoplasmic

expressions, of Fb-3 in neoplastic cells were revealed.

Conclusion:

Our findings stress the role of AQP1 and Fb-3 in MPM

tumourigenesis, with a potential diagnostic and prognostic role.

PS-21-003

Two rare dedifferentiated bone tumours

C. Quadros

*

, J. Tavares, R. Luís, D. López-Presa

*

Hospital de Santa Maria, Lisbon, Portugal

Objective:

In dedifferentiated osseous neoplasias two distinct con-

stituents can be observed: a low-grade well differentiated sarcoma

and a high-grade dedifferentiated sarcoma, the latest dictating the

overall prognosis. We present two cases of dedifferentiated bone

tumours.

Method:

Case 1: a 55 year-old woman with a history of

sacrococcygeal chordoma treated with surgery, chemotherapy and

radiotherapy, complained of bilateral lumbar pain, paresthesias and

hypoesthesias during a follow-up appointment; imaging studies

revealed a volumous lesion within the sacrococcygeal region; the

patient was re-interventioned. Case 2: a 66 year-old man with a

negligible medical background, presented with a femoral patho-

logic fracture; an intra-medullary lesion was identified

intraoperatively.

Results:

Case 1: the diagnosis of a dedifferentiated chordoma was

established, unfortunately without follow-up information for con-

trol since the patient belonged to other institution. Case 2: the

surgical specimen heralded a biphasic tumour displaying a well-

differentiated chondrosarcoma component and a high-grade sarco-

matous component with epithelioid morphology; the clinical man-

agement remains to be decided through multidisciplinary

consensus.

Conclusion:

Chordoma is a rare tumour and its dedifferentiated variant

represents an exceedingly rare entity. Dedifferentiated chondrosarcoma is

also an uncommon neoplasm which develops only in 10

15 % of the

central chondrosarcomas. We report two cases of such entities and a

review of the literature.

PS-21-004

Robust and reproducible pathologist training for PD-L1 assessing

tumour cells (TC) and immune cells (IC) utilising novel digital train-

ing platform

E. Dennis

*

, B. Vennapusa, E. ElGabry, E. Walker, D. Smith, J. Cardona,

M. Kockx

*

Ventana Medical Systems, Inc, Medical Affairs, Tucson, USA

Objective:

PD-L1 expressed on TC and IC plays an important role in

down-regulating anti-cancer immune responses and may predict benefit

of PD-L1/PD-1 inhibitors. Thus, assessment of TC and IC is incorpo-

rated in the VENTANA PD-L1 (SP142) Assay (SP142 Assay) scoring

algorithm. IC scoring is a new parameter for companion diagnostics

and pathologist training is recommended. Traditional glass slide training

covering one specific cut-off is expensive, time-consuming and chal-

lenging for broad global reach. An innovative approach was developed

to provide a standardized, robust and practical training model.

Method:

A universal scoring approach with TC and IC bins for

non-small cell lung cancer (NSCLC) and IC bins for urothelial

cancer (UC) was developed. A novel digital platform was custom-

ized with a rapid, user-friendly interface, facilitating monitoring of

scores and reporting. 74 cases, each with three slides (H&E, neg-

ative control, SP142 IHC) were uploaded. A global train-the-

trainer program enabled local training sessions to be conducted

using the digital platform.

Results:

410 pathologists were trained in 29 countries. Average

Proficiency Test score was 94 % and pathologist satisfaction score 4.7/5.

Conclusion:

SP142 Assay training for TCs and ICs across the dynamic

range of staining on a novel digital training platform is robust and suc-

cessful with excellent pathologist concordance scores.

Wednesday, 6 September 2017, 09:30

10:30, Hall 3

PS-21 Other Topics

Virchows Arch

(

2017

)

471

(

Suppl 1

):

S1

S352

S247